南玻B(200012) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 2,785,709,687, a decrease of 7.35% compared to CNY 3,006,832,539 in the same period last year[4] - Net profit attributable to shareholders was CNY 383,682,831, down 33.07% from CNY 573,268,793 year-on-year[6] - The net cash flow from operating activities was CNY 102,057,062, a significant decline of 70.10% compared to CNY 341,291,798 in the previous year[6] - Basic and diluted earnings per share were both CNY 0.12, representing a decrease of 36.84% from CNY 0.19 in the same period last year[6] - Total operating revenue for the current period is CNY 2,785,709,687, a decrease of 7.36% from CNY 3,006,832,539 in the previous period[47] - Net profit attributable to shareholders of the parent company is CNY 383,682,831, down 33.16% from CNY 573,268,793 in the previous period[50] - The company reported a net cash flow from operating activities of CNY 102,057,062, a significant decrease from CNY 341,291,798 in the previous period[53] Assets and Liabilities - Total assets increased by 3.81% to CNY 20,699,582,452 from CNY 19,939,364,510 at the end of the previous year[6] - The company’s total liabilities increased to CNY 8,452,808,457, up from CNY 8,072,890,275 in the previous period[46] - Current assets totaled RMB 6.53 billion, up from RMB 6.31 billion at the beginning of the year[43] - Fixed assets increased to RMB 9.11 billion from RMB 8.57 billion at the beginning of the year[43] - Total assets amounted to RMB 20.70 billion, an increase from RMB 19.94 billion at the beginning of the year[41] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 157,188[30] - The largest shareholder, Qianhai Life Insurance Co., Ltd., held 15.19% of the shares, totaling 466,386,874 shares[30] - Total equity attributable to shareholders of the parent company rose to CNY 11,805,984,216, compared to CNY 11,429,661,046 in the previous period[46] Income and Expenses - The company reported a significant increase in investment income, which rose by 518% to CNY 8,493,186 from CNY 1,373,392 in the previous year[12] - Total operating costs increased to CNY 2,385,993,949, up 3.48% from CNY 2,306,236,702 in the previous period[47] - Financial expenses decreased mainly due to a reduction in interest expenses[31] - The company’s financial expenses decreased to CNY 30,893,854 from CNY 46,480,853 in the previous period[47] - Investment income increased primarily due to an increase in structured deposit income[31] - Asset impairment losses decreased mainly due to the write-off of inventory impairment provisions by subsidiaries[31] - Asset disposal gains increased mainly due to increased gains from the disposal of assets by certain subsidiaries[31] - Other income increased mainly due to an increase in deferred income amortization by certain subsidiaries[31] - Non-operating income decreased mainly due to a reduction in claims income and uncollectible amounts[31] Inventory and Production - The company's inventory increased by 39% to CNY 1,516,472,480, driven by production resumption and changes in sales rhythm[12] Research and Development - Research and development expenses for the current period were CNY 111,661,597, an increase from CNY 104,095,372 in the previous period[47] Future Plans - The company plans to focus on market expansion and new product development in the upcoming quarters[49]